<DOC>
	<DOC>NCT00680017</DOC>
	<brief_summary>The objective of this study is to evaluate the safety and efficacy of the combination of ABT-335 plus rosuvastatin in dyslipidemic subjects with Chronic Kidney Disease (CKD) Stage 3.</brief_summary>
	<brief_title>30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency, Chronic</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Fenofibric acid</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Inclusion Criteria Dyslipidemic participants with Chronic Kidney Disease Stage 3 For entry into the Treatment Phase (Visit 3), the participant satisfied the following laboratory criteria (measured at the Screening Visit[s]): Estimated glomerular filtration rate between 30 and 59 mL/min/1.73 m2 (Chronic Kidney Disease Stage 3) by simplified 4 variable Modification of Diet in Renal Disease formula (this includes a 10 percent variation in the upper limit of estimated glomerular filtration rate that was allowed for the enrollment of participants to account for variability in the creatinine assay). Fasting lipid results following greater than or equal to 12hour fasting period: Triglycerides level greater than or equal to 150 mg/dL, Highdensity lipoprotein cholesterol less than 40 mg/dL for males and less than 50 mg/dL for females, and Lowdensity lipoprotein cholesterol greater than or equal to 130 mg/dL Exclusion Criteria Participants with certain chronic or unstable medical conditions. Participants with unstable dose of medications or receiving coumarin anticoagulants, systemic cyclosporine, or certain other medications. Pregnant or lactating women, or women intending to become pregnant. Participants with diabetes mellitus that is poorly controlled. Participants of Asian ancestry (having Filipino, Chinese, Japanese, Korean, Vietnamese, or AsianIndian origin).</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Dyslipidemia</keyword>
	<keyword>Kidney Disease</keyword>
</DOC>